Public list Pharma Startups (6570)
:was a technology developer in the fields of glycobiology and proteomics. Utilizing its technology, the company developed a lead pharmaceutical product Zavesca, that was approved by the European Commission, and established proteomics collaborations wi...Show all
Company (Acquired)
Phone:
1950 Lake Park Drive
Smyrna, 30080
Georgia, United States
Total Funding | Date of Last Funding | |
---|---|---|
Oxford Glycosciences | $50M | Apr 11, 2003 |
See all 15 competitors |
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Ephrin-b receptor protein involved in carcinoma | Apr 09, 2003 | Feb 02, 2010 | Patent |